{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:25:35Z","timestamp":1789802735534,"version":"4.0.1"},"reference-count":82,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001317","name":"Swansea University","doi-asserted-by":"publisher","award":["RIO 034-20"],"award-info":[{"award-number":["RIO 034-20"]}],"id":[{"id":"10.13039\/501100001317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,1,9]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"\n Objectives<\/jats:title>\n We aimed to investigate the feasibility of a cluster randomised controlled trial (RCT) of the ADRe Profile in UK primary care. The ADRe Profile is a patient monitoring system to identify and address adverse drug reactions (ADR) and ADR-related issues to pre-empt clinical deterioration.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n A preliminary study to test the feasibility of an RCT.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n General practices (GPs) in South-West Wales, UK.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n 20 patients aged >64\u2009and prescribed >4 long-term medicines.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants reported their health-related problems using the ADRe-Profile. Participants completed the profile independently initially, then with researcher support, capturing vital signs, clinical observations and patient-reported symptoms.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n Feasibility was assessed based on recruitment, retention, adherence to protocols, potential for clinical impact and staff costs.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n We recruited two GP practices (0.94% of 213 contacted), and 20 patients aged >64 (51.3% of those approached). Retention was 100%. ADRe Profiles had a 98.29% completion rate, identifying 289 clinical problems, including pain (16 of 20 patients), dyspnoea (10\/20), dizziness (8\/20), bleeding\/bruising (7\/20) and falls (4\/20). Most problems (90%) and vital signs (78%) recorded on ADRe Profiles were absent from existing patient records. Researchers recommended further investigations (164 instances) and interventions (126 suggestions). Despite the potential for clinical benefits, engagement from clinicians was limited. Cost estimates for ADRe administration ranged from \u00a340 to \u00a373, within the funding available from Health and Care Research Wales.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n An RCT of the ADRe Profile was feasible, despite gatekeeping by clinicians. Recruitment of GP practices was challenging, with <1% of eligible practices participating. In contrast, patient recruitment and retention were successful. ADRe aligns with WHO patient safety goals and could improve healthcare by addressing ADR-related problems proactively in this vulnerable population.<\/jats:p>\n <\/jats:sec>\n \n Trial registration number<\/jats:title>\n \n NCT04663360<\/jats:ext-link>\n ; Pre-Results.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-099627","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:02:55Z","timestamp":1771322575000},"page":"e099627","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Breaking barriers: feasibility of a cluster randomised trial evaluating an instrument for identifying and ameliorating adverse drug reactions"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct04663360","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04663360","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Vera","family":"Logan","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7631-7763","authenticated-orcid":false,"given":"David","family":"Hughes","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Turner","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-8661","authenticated-orcid":false,"given":"Neil","family":"Carter","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-2987","authenticated-orcid":false,"given":"Sue","family":"Jordan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"2026012705101104000_16.1.e099627.1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015570104121"},{"key":"2026012705101104000_16.1.e099627.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.9.1107"},{"key":"2026012705101104000_16.1.e099627.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062589","article-title":"Healthcare costs of adverse drug reactions and potentially inappropriate prescribing in older adults: a population-based study","volume":"12","author":"Robinson","year":"2022","journal-title":"BMJ Open"},{"key":"2026012705101104000_16.1.e099627.4","doi-asserted-by":"crossref","DOI":"10.1177\/20420986221080796","article-title":"Ten-year trends in adverse drug reaction-related hospitalizations among people with dementia","volume":"13","author":"Zaidi","year":"2022","journal-title":"Ther Adv Drug Saf"},{"key":"2026012705101104000_16.1.e099627.5","unstructured":"All Wales Medicines Strategy Group . Polypharmacy in older people. 2023. Available: https:\/\/awttc.nhs.wales\/medicines-optimisation-and-safety\/medicines-optimisation-guidance-resources-and-data\/prescribing-guidance\/polypharmacy-in-older-people-a-guide-for-healthcare-professionals\/ [Accessed 06 Jan 2026]."},{"key":"2026012705101104000_16.1.e099627.6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055551","article-title":"Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions","volume":"12","author":"Osanlou","year":"2022","journal-title":"BMJ Open"},{"key":"2026012705101104000_16.1.e099627.7","unstructured":"The King\u2019s Fund . The NHS budget and how it has changed. 2024. Available: https:\/\/www.kingsfund.org.uk\/insight-and-analysis\/data-and-charts\/nhs-budget-nutshell [Accessed 6 Jan 2026]."},{"key":"2026012705101104000_16.1.e099627.8","first-page":"35","article-title":"Adverse drug reactions: reducing the burden of treatment","volume":"21","author":"Jordan","year":"2007","journal-title":"Nurs Stand"},{"key":"2026012705101104000_16.1.e099627.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244519","article-title":"Nobody ever questions\u2014Polypharmacy in care homes: A mixed methods evaluation of a multidisciplinary medicines optimisation initiative","volume":"16","author":"Jordan","year":"2021","journal-title":"PLoS ONE"},{"key":"2026012705101104000_16.1.e099627.10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40264-023-01274-8","article-title":"Preventable Deaths Involving Medicines: A Systematic Case Series of Coroners\u2019 Reports 2013-22","volume":"46","author":"France","year":"2023","journal-title":"Drug Saf"},{"key":"2026012705101104000_16.1.e099627.11","unstructured":"World Health Organization . Medication without harm: policy brief. 2024. Available: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/1eacccb6-838e-4787-bfd9-4bdeb4debfcf\/content [Accessed 06 Jan 2026]."},{"key":"2026012705101104000_16.1.e099627.12","unstructured":"World Health Organisation . Medication safety in polypharmacy. 2019. Available: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325454\/WHO-UHC-SDS-2019.11-eng.pdf?ua=1 [Accessed 06 Jan 2026]."},{"key":"2026012705101104000_16.1.e099627.13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/geriatrics5040079","article-title":"Looking for the \u201cLittle Things\u201d: A Multi-Disciplinary Approach to Medicines Monitoring for Older People Using the ADRe Resource","volume":"5","author":"Hughes","year":"2020","journal-title":"Geriatrics"},{"key":"2026012705101104000_16.1.e099627.14","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101096","article-title":"Barriers and facilitators to deprescribing in primary care: a systematic review","volume":"4","author":"Doherty","year":"2020","journal-title":"BJGP Open"},{"key":"2026012705101104000_16.1.e099627.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0317660","article-title":"Methods for identifying adverse drug reactions in primary care: A systematic review","volume":"20","author":"Logan","year":"2025","journal-title":"PLoS One"},{"key":"2026012705101104000_16.1.e099627.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140203","article-title":"Nurse-Led Medicines\u2019 Monitoring for Patients with Dementia in Care Homes: A Pragmatic Cohort Stepped Wedge Cluster Randomised Trial","volume":"10","author":"Jordan","year":"2015","journal-title":"PLoS ONE"},{"key":"2026012705101104000_16.1.e099627.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096682","article-title":"Medication Monitoring in a Nurse-Led Respiratory Outpatient Clinic: Pragmatic Randomised Trial of the West Wales Adverse Drug Reaction Profile","volume":"9","author":"Gabe","year":"2014","journal-title":"PLoS ONE"},{"key":"2026012705101104000_16.1.e099627.18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.2002.02064.x"},{"key":"2026012705101104000_16.1.e099627.19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/843621","article-title":"Medication Monitoring for People with Dementia in Care Homes: The Feasibility and Clinical Impact of Nurse-Led Monitoring","volume":"2014","author":"Jordan","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"2026012705101104000_16.1.e099627.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220885","article-title":"Nurse-led medicines\u2019 monitoring in care homes, implementing the Adverse Drug Reaction (ADRe) Profile improvement initiative for mental health medicines: An observational and interview study","volume":"14","author":"Jordan","year":"2019","journal-title":"PLoS ONE"},{"key":"2026012705101104000_16.1.e099627.21","doi-asserted-by":"publisher","DOI":"10.7748\/ns.2016.e10447"},{"key":"2026012705101104000_16.1.e099627.22","unstructured":"Cochrane AL . Effectiveness and efficiency: random reflections on health services. London: Nuffield Provincial Hospitals Trust, 1972."},{"key":"2026012705101104000_16.1.e099627.23","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-7-9","article-title":"What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies","volume":"7","author":"McDonald","year":"2006","journal-title":"Trials"},{"key":"2026012705101104000_16.1.e099627.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015276","article-title":"Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme","volume":"7","author":"Walters","year":"2017","journal-title":"BMJ Open"},{"key":"2026012705101104000_16.1.e099627.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000738","article-title":"Availability of results of clinical trials registered on EU Clinical Trials Register: cross sectional audit study","volume":"3","author":"DeVito","year":"2024","journal-title":"BMJ Med"},{"key":"2026012705101104000_16.1.e099627.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6924.283"},{"key":"2026012705101104000_16.1.e099627.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k4645","article-title":"Research waste is still a scandal\u2014an essay by Paul Glasziou and Iain Chalmers","volume":"363","author":"Glasziou","year":"2018","journal-title":"BMJ"},{"key":"2026012705101104000_16.1.e099627.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1655","article-title":"Developing and evaluating complex interventions: the new Medical Research Council guidance","volume":"337","author":"Craig","year":"2008","journal-title":"BMJ"},{"key":"2026012705101104000_16.1.e099627.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"2026012705101104000_16.1.e099627.30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150205","article-title":"Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework","volume":"11","author":"Eldridge","year":"2016","journal-title":"PLoS ONE"},{"key":"2026012705101104000_16.1.e099627.31","doi-asserted-by":"publisher","DOI":"10.1002\/nur.20147"},{"key":"2026012705101104000_16.1.e099627.32","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-018-0290-8","article-title":"Exploratory studies to decide whether and how to proceed with full-scale evaluations of public health interventions: a systematic review of guidance","volume":"4","author":"Hallingberg","year":"2018","journal-title":"Pilot Feasibility Stud"},{"key":"2026012705101104000_16.1.e099627.33","first-page":"171","article-title":"Nuts and Bolts of Conducting Feasibility Studies","volume":"67","author":"Tickle-Degnen","year":"2013","journal-title":"OTJR (Thorofare N J)"},{"key":"2026012705101104000_16.1.e099627.34","unstructured":"Office for Health Improvement and Disparities . Guidance - feasibility study. 2020. Available: https:\/\/www.gov.uk\/guidance\/feasibility-study [Accessed 06 Jan 2026]."},{"key":"2026012705101104000_16.1.e099627.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016970","article-title":"Quality of reporting of pilot and feasibility cluster randomised trials: a systematic review","volume":"7","author":"Chan","year":"2017","journal-title":"BMJ Open"},{"key":"2026012705101104000_16.1.e099627.36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271819","article-title":"Changes in key recruitment performance metrics from 2008\u20132019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.gov","volume":"17","author":"Br\u00f8gger-Mikkelsen","year":"2022","journal-title":"PLoS ONE"},{"key":"2026012705101104000_16.1.e099627.37","unstructured":"British Medical Association . Pressures in general practice data analysis. 2022. Available: https:\/\/www.bma.org.uk\/advice-and-support\/nhs-delivery-and-workforce\/pressures\/pressures-in-general-practice-data-analysis [Accessed 06 Jan 2026]."},{"key":"2026012705101104000_16.1.e099627.38","unstructured":"King\u2019s Fund . Naming the issue: chronic excessive workload in the NHS. 2021. Available: https:\/\/www.kingsfund.org.uk\/blog\/2021\/06\/naming-issue-chronic-excessive-workload-nhs [Accessed 06 Jan 2026]."},{"key":"2026012705101104000_16.1.e099627.39","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n1603","article-title":"Parliamentary report on workforce burnout and resilience","volume":"373","author":"Bailey","year":"2021","journal-title":"BMJ"},{"key":"2026012705101104000_16.1.e099627.40","unstructured":"Care Quality Commission . The health and care workforce. 2023. Available: https:\/\/www.cqc.org.uk\/publications\/major-report\/state-care\/2022-2023\/workforce [Accessed 22 Sep 2024]."},{"key":"2026012705101104000_16.1.e099627.41","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp23X732045"},{"key":"2026012705101104000_16.1.e099627.42","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-019-0499-1","article-title":"Guidelines for reporting non-randomised pilot and feasibility studies","volume":"5","author":"Lancaster","year":"2019","journal-title":"Pilot Feasibility Stud"},{"key":"2026012705101104000_16.1.e099627.43","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"key":"2026012705101104000_16.1.e099627.44","unstructured":"Office for National Statistics (ONS) . ONS website, statistical bulletin, regional economic activity by gross domestic product, UK: 1998 to 2022. 2024. Available: https:\/\/www.ons.gov.uk\/economy\/grossdomesticproductgdp\/bulletins\/regionaleconomicactivitybygrossdomesticproductuk\/1998to2022 [Accessed 24 Aug 2024]."},{"key":"2026012705101104000_16.1.e099627.45","unstructured":"Worldmeter . 2024. Available: https:\/\/www.worldometers.info\/gdp\/gdp-per-capita\/"},{"key":"2026012705101104000_16.1.e099627.46","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-021-00770-x","article-title":"Determining sample size for progression criteria for pragmatic pilot RCTs: the hypothesis test strikes back!","volume":"7","author":"Lewis","year":"2021","journal-title":"Pilot Feasibility Stud"},{"key":"2026012705101104000_16.1.e099627.47","unstructured":"Uitenbroek DG . SISA binomial. 1997. Available: https:\/\/www.sgapeio.es\/INFORMEST\/VICongreso\/taller\/applets\/Sisa\/ [Accessed 01 Jan 2023]."},{"key":"2026012705101104000_16.1.e099627.48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013537","article-title":"Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies","volume":"7","author":"Avery","year":"2017","journal-title":"BMJ Open"},{"key":"2026012705101104000_16.1.e099627.49","unstructured":"Welsh Government - StatsWales . Patients registered at a GP practice. 2022. Available: https:\/\/statswales.gov.wales\/Catalogue\/Health-and-Social-Care\/General-Medical-Services\/General-practice-population\/patients-registered-at-a-gp-practice [Accessed 14 Feb 2024]."},{"key":"2026012705101104000_16.1.e099627.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2018.08.013"},{"key":"2026012705101104000_16.1.e099627.51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jir.13216","article-title":"A Scoping Review of the Ways Gatekeepers May Hinder or Promote Opportunities for People With Intellectual and\/or Developmental Disabilities to Learn About Research Participation","volume":"69","author":"Brodeur","year":"2025","journal-title":"J Intellect Disabil Res"},{"key":"2026012705101104000_16.1.e099627.52","unstructured":"Taylor B , Lobont C , Dayan M , et al . Public satisfaction with the NHS and social care in 2024 (BSA). 2025. Available: https:\/\/www.kingsfund.org.uk\/insight-and-analysis\/reports\/public-satisfaction-nhs-social-care-in-2024-bsa [Accessed 12 Nov 2025]."},{"key":"2026012705101104000_16.1.e099627.53","doi-asserted-by":"publisher","DOI":"10.1080\/10503307.2014.935520"},{"key":"2026012705101104000_16.1.e099627.54","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-022-06865-x","article-title":"Factors associated with recruitment to randomised controlled trials in general practice: a systematic mixed studies review","volume":"24","author":"Moffat","year":"2023","journal-title":"Trials"},{"key":"2026012705101104000_16.1.e099627.55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12875-022-01898-2","article-title":"Clinical trial recruitment in primary care: exploratory factor analysis of a questionnaire to measure barriers and facilitators to primary care providers\u2019 involvement","volume":"23","author":"Millar","year":"2022","journal-title":"BMC Prim Care"},{"key":"2026012705101104000_16.1.e099627.56","unstructured":"British Medical Association . NHS under pressure \u2013 Wales. 2025. Available: https:\/\/www.bma.org.uk\/advice-and-support\/nhs-delivery-and-workforce\/pressures\/nhs-under-pressure-wales#:~:text=GP%20appointments%20and%20referrals&text=Wales%20also%20has%20fewer%20individual,to%20meet%20the%20OECD%20average [Accessed 02 Jul 2025]."},{"key":"2026012705101104000_16.1.e099627.57","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-020-1100-y","article-title":"The University of Limerick Education and Research Network for General Practice (ULEARN-GP): practice characteristics and general practitioner perspectives","volume":"21","author":"O\u2019Regan","year":"2020","journal-title":"BMC Fam Pract"},{"key":"2026012705101104000_16.1.e099627.58","doi-asserted-by":"crossref","DOI":"10.1155\/jonm\/9921349","article-title":"Reducing Adverse Drug Reactions for Older People in the Community: Evaluating the Validity and Reliability of the ADRe Profile","volume":"2025","author":"Logan","year":"2025","journal-title":"J Nurs Manag"},{"key":"2026012705101104000_16.1.e099627.59","unstructured":"Office for National Statistics . Internet users, UK. 2021. Available: https:\/\/www.ons.gov.uk\/businessindustryandtrade\/itandinternetindustry\/bulletins\/internetusers\/2020 [Accessed 06 Jan 2026]."},{"key":"2026012705101104000_16.1.e099627.60","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/08959420.2020.1759758","article-title":"Recovering from the COVID-19 Pandemic: A Focus on Older Adults","volume":"32","author":"Morrow-Howell","year":"2020","journal-title":"J Aging Soc Policy"},{"key":"2026012705101104000_16.1.e099627.61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/polsoc\/puab016","article-title":"Digitalization and beyond: the effects of Covid-19 on post-pandemic educational policy and delivery in Europe","volume":"41","author":"Zancajo","year":"2022","journal-title":"Policy and Society"},{"key":"2026012705101104000_16.1.e099627.62","unstructured":"UK Government . Digital by default proposed for government services, press release. 2010. Available: https:\/\/www.gov.uk\/government\/news\/digital-by-default-proposed-for-government-services [Accessed 12 Dec 2023]."},{"key":"2026012705101104000_16.1.e099627.63","unstructured":"UK Government . GOV.UK: making public service delivery digital by default, press release. 2012. Available: https:\/\/www.gov.uk\/government\/news\/launch-of-gov-uk-a-key-milestone-in-making-public-service-delivery-digital-by-default [Accessed 12 Dec 2023]."},{"key":"2026012705101104000_16.1.e099627.64","unstructured":"UK Government, UK Digital Strategy . Department for digital, culture, media & sport, policy paper. 2022. Available: https:\/\/www.gov.uk\/government\/publications\/uks-digital-strategy\/uk-digital-strategy [Accessed 15 Dec 2022]."},{"key":"2026012705101104000_16.1.e099627.65","doi-asserted-by":"publisher","DOI":"10.1177\/2042098615615472"},{"key":"2026012705101104000_16.1.e099627.66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s41999-021-00481-9","article-title":"Adverse drug reactions in older adults: a narrative review of the literature","volume":"12","author":"Zazzara","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"2026012705101104000_16.1.e099627.67","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.4.526"},{"key":"2026012705101104000_16.1.e099627.68","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13020323","article-title":"Potentially Inappropriate Prescribing and Potential Prescribing Omissions and Their Association with Adverse Drug Reaction-Related Hospital Admissions","volume":"13","author":"Brannigan","year":"2024","journal-title":"J Clin Med"},{"key":"2026012705101104000_16.1.e099627.69","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s11096-020-00976-8","article-title":"Prevalence and risk factors of drug-related problems identified in pharmacy-based medication reviews","volume":"42","author":"Sell","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"2026012705101104000_16.1.e099627.70","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1029067","article-title":"Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients","volume":"13","author":"Cahir","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026012705101104000_16.1.e099627.71","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7456.15"},{"key":"2026012705101104000_16.1.e099627.72","unstructured":"NHS England . Primary care patient safety strategy. 202405. Available: https:\/\/www.england.nhs.uk\/long-read\/primary-care-patient-safety-strategy\/#:~:text=The%20LFPSE%20service%20replaces%20the,of%20learning%20and%20embedding%20change [Accessed 29 Oct 2025]."},{"key":"2026012705101104000_16.1.e099627.73","unstructured":"Logan V . Medication monitoring in general practice: clinical impact of implementing a nurse-led adverse drug reaction (ADRe) profile in older adults with 5 or more prescribed medicines [PhD. Thesis]. 2024 Available: https:\/\/sciprofiles.com\/publication\/view\/258e56e9ee5aba230920f286f2dd215c"},{"key":"2026012705101104000_16.1.e099627.74","first-page":"61","article-title":"Using nurse-led patient monitoring to avoid medicines-related harm","volume":"36","author":"Jordan","year":"2021","journal-title":"Nurs Stand"},{"key":"2026012705101104000_16.1.e099627.75","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/S2666-7568(23)00086-7","article-title":"Organisational factors associated with hospital costs and patient mortality in the 365 days following hip fracture in England and Wales (REDUCE): a record-linkage cohort study","volume":"4","author":"Baji","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"2026012705101104000_16.1.e099627.76","unstructured":"Department for Health and Social Care (DHSC) . Good for you, good for us, good for everybody. 2021. Available: https:\/\/assets.publishing.service.gov.uk\/media\/614a10fed3bf7f05ab786551\/good-for-you-good-for-us-good-for-everybody.pdf [Accessed 06 Jan 2026]."},{"key":"2026012705101104000_16.1.e099627.77","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.121349"},{"key":"2026012705101104000_16.1.e099627.78","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048178","article-title":"Progression from external pilot to definitive randomised controlled trial: a methodological review of progression criteria reporting","volume":"11","author":"Mellor","year":"2021","journal-title":"BMJ Open"},{"key":"2026012705101104000_16.1.e099627.79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bushor.2009.10.006","article-title":"The normalization of deviance in healthcare delivery","volume":"53","author":"Banja","year":"2010","journal-title":"Bus Horiz"},{"key":"2026012705101104000_16.1.e099627.80","doi-asserted-by":"crossref","DOI":"10.1177\/01939459211030334","article-title":"Normalization of Deviance","volume":"44","author":"Wright","year":"2022","journal-title":"West J Nurs Res"},{"key":"2026012705101104000_16.1.e099627.81","doi-asserted-by":"publisher","DOI":"10.1177\/1049732317697102"},{"key":"2026012705101104000_16.1.e099627.82","unstructured":"Welsh Government - StatsWales . Welsh index of multiple deprivation. 2019. Available: https:\/\/statswales.gov.wales\/Catalogue\/Community-Safety-and-Social-Inclusion\/Welsh-Index-of-Multiple-Deprivation [Accessed 02 Sep 2024]."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-099627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:03:07Z","timestamp":1771322587000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-099627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,27]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjopen-2025-099627"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-099627","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}